Aware Behavioral Health

Aware Behavioral Health in Dallas, Texas offers Spravato for adults with treatment-resistant depression who have not responded to conventional antidepressants. The FDA-approved esketamine nasal spray targets glutamate and NMDA receptors to enhance synaptic connections, with many patients experiencing improvement within hours to days.

Spravato is administered in-office under medical supervision, with a pre-treatment assessment, self-administered dosing, and at least two hours of observation afterward. The structured schedule begins with two treatments weekly for the first four weeks, then weekly or biweekly maintenance, and patients arrange a driver home.

Led by Dr. Sehdev, who has extensive experience treating depression, the practice also offers TMS therapy, medication management, and therapy. The team creates a personalized plan for each patient to help achieve lasting improvement.